Funding Round
Neurolutions raises $16.5M Series B for IpsiHand BCI stroke rehab system European launch
Medical Product Outsourcing2/17/2026·02/17/26🌐 USA
Summary
St. Louis-based Neurolutions closed $16.5M Series B led by Ascension Ventures, with Cultivation Capital and St. Louis Arch Angels. IpsiHand received CE mark in Q3 2023 and the round funds European commercial launch through Neurolutions EMEA in Germany, France, and UK, targeting 200 stroke rehabilitation centers in year one.
Why it matters
CE mark followed immediately by a commercial round and European entity establishment is a textbook MedTech international expansion playbook. The 200-center year-one target is ambitious but achievable given that IpsiHand has peer-reviewed evidence and FDA Breakthrough Device status.
#BCI#Europe#Industry#Stroke Rehabilitation#USA#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in